USANA Health Sciences, Inc. booked $925.3M in FY2025 revenue, growing 8.3% year over year — faster than most Consumer Defensive companies we track, at a 1.2% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.